Oracle Corporation Class Action Lawsuit

Robbins LLP is Investigating Allegations that Oracle Corporation (ORCL) Misled Investors Regarding the Amount of Money Needed for its AI Buildout

Robbins LLP informs investors that a class action was filed on behalf of all persons and/or entities who purchased or otherwise acquired Oracle Corporation (NYSE: ORCL) Senior Notes issued pursuant to the Shelf Registration Statement filed with the SEC on March 15, 2024, and as supplemented on September 25, 2025. Oracle is an Austin, Texas-based company that sells database software, enterprise applications, and cloud infrastructure and hardware.

The Allegations

According to the complaint, on September 10, 2025, Oracle and OpenAI OpCo, LLC announced a $300 billion, five-year cloud computing contract, to supply OpenAI with computing power. On September 25, 2025, Oracle issued Senior Notes, comprising of $18 billion in bonds, to fund its AI infrastructure expansion. Plaintiff alleges that the Offering did not disclose that further significant debt would be required to fund the Oracle–OpenAI agreement.

The complaint alleges that unbeknownst to investors, Oracle needed to raise a significant amount of additional debt to build the AI infrastructure. Specifically, on November 13, 2025 (just seven weeks after issuing the Senior Notes), reports emerged that Oracle was looking to raise an additional $38 billion in debt sales to help fund its AI buildout. The $38 billion would consist of $23 billion and $15 billion term loans led by various banks. Proceeds from the loan would fund two data centers developed by Vantage Data Centers in Wisconsin and Texas—data centers that would support the Oracle–Open AI agreement. On this news, Oracle's Senior Notes began to trade with yields and spreads similar to lower-rated issuers as investors began to demand higher yields due to perceived credit risk.


What Now: You may be eligible to participate in the class action against Oracle Corporation. Bondholders who wish to serve as lead plaintiff for the class should contact Robbins LLP. The lead plaintiff is a representative party who acts on behalf of other class members in directing the litigation.  You do not have to participate in the case to be eligible for a recovery. If you choose to take no action, you can remain an absent class member.

All representation is on a contingency fee basis. Shareholders pay no fees or expenses. 

Send us a message for more information.

Additional Alerts for Shareholders

Pharmaceutist reaching for medications on pharmacy shelves

uniQure N.V. Class Action Lawsuit

Robbins LLP is Investigating Allegations that uniQure (QURE) Misled Investors Regarding the Likelihood of FDA Approval of its Leading Drug Candidate, AMT-130 Robbins LLP informs stockholders

Read More »
Free!
Skip to content